C12N 2500/90
Serum-free medium, which may still contain naturally-sourced components
C12N2500/90 (Serum-free medium, which may still contain naturally-sourced components) appears on 967 US grants and 1,521 published applications in this corpus.
Search patents in C12N- Granted patents
- 967
- Published applications
- 1,521
- Assignees
- 744
- Inventors
- 2,408
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 3 | 0 |
| 1991 | 2 | 0 |
| 1992 | 6 | 0 |
| 1993 | 3 | 0 |
| 1994 | 6 | 0 |
| 1995 | 9 | 0 |
| 1996 | 7 | 0 |
| 1997 | 16 | 0 |
| 1998 | 28 | 0 |
| 1999 | 14 | 0 |
| 2000 | 22 | 0 |
| 2001 | 13 | 10 |
| 2002 | 23 | 36 |
| 2003 | 15 | 40 |
| 2004 | 9 | 30 |
| 2005 | 6 | 47 |
| 2006 | 19 | 54 |
| 2007 | 14 | 49 |
| 2008 | 18 | 53 |
| 2009 | 25 | 55 |
| 2010 | 19 | 63 |
| 2011 | 27 | 59 |
| 2012 | 38 | 76 |
| 2013 | 41 | 50 |
| 2014 | 48 | 59 |
| 2015 | 40 | 75 |
| 2016 | 52 | 81 |
| 2017 | 45 | 79 |
| 2018 | 48 | 70 |
| 2019 | 61 | 69 |
| 2020 | 50 | 74 |
| 2021 | 64 | 73 |
| 2022 | 35 | 86 |
| 2023 | 38 | 77 |
| 2024 | 23 | 61 |
| 2025 | 43 | 55 |
| 2026 | 30 | 40 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Ex vivo proliferation of epithelial cells29 Sep 2026US 12,747,425 B2Propagenix Inc.
- K562 universal antigen presenting cells and uses thereof15 Sep 2026US 12,734,239 B2Board of Regents, The University of Texas System
- Media and methods for differentiating natural killer cells1 Sep 2026US 12,723,233 B2Stemcell Technologies Canada Inc.
- Media for culturing naive human pluripotent stem cells14 Jul 2026US 12,680,083 B2Yeda Research and Development Co. Ltd.
- Serum-free medium not containing albumin and suited for culturing human hematopoietic stem cells, and albumin-free culturing method7 Jul 2026US 12,674,139 B2The University of Tokyo
- Pluripotent stem cell that can be isolated from body tissue1 Oct 2026US 2026/0297512 A1MuseCell Innovations Pte. Ltd.
- Epithelial Stem Cells and Production and Uses thereof10 Sep 2026US 2026/0265690 A1Stemson Therapeutics Corp.
- Generation of induced neutrophils with increased activation and transmigration capabilities10 Sep 2026US 2026/0265695 A1
- Suspension mode seed train development for adherent cells10 Sep 2026US 2026/0265701 A1Sarepta Therapeutics, Inc.
- Engineered cells and methods of use3 Sep 2026US 2026/0256838 A1The Regents of the University of California
Most cited
By later US patents
- Serum-free, synthetic, completely chemically defined tissue culture media450US 4,657,866 A1987
- Cell culture medium with antioxidant409US 4,927,762 ACell Enterprises, Inc. · 1990
- In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny316US 5,750,376 ANeurospheres Holdings Ltd. · 1998
- In vitro growth and proliferation of multipotent neural stem cells and their progeny265US 5,851,832 ANeurospheres, Ltd. · 1998
- Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals223US 5,753,506 ACNS Stem Cell Technology, Inc. · 1998